InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: Ubertino post# 71053

Wednesday, 08/14/2013 12:38:26 PM

Wednesday, August 14, 2013 12:38:26 PM

Post# of 146240
Nanopatent, once the Cides start to get fast tracked to the market, the era of antiviral "host enhancing" vaccines will come to a close. Big Pharma will have to adapt to the new "good science". Nanoviricides, Inc. footprint in the world, both healthwise and economic, will be greatly aclaimed by the people, the beneficiaries. "...Billions of dollars of stress on personal savings, Social Security, and Medicare each year. And the “cost” of illness — both in dollars and pain — only grows with age…" ~ Patrick Cox.

As you well know, Nanoviricides, Inc. has prestigious universities, institutions, collaborators. From the BigKahuna/Dr. Seymour " ...However, that being said, we are trying to hit the June 30th mark for sending in the request to the FDA for a meeting. Unfortunately, whether we can or cannot meet that date is not up to us and is predicated on getting back the additional data we need from our collaborators for the initial request. We also have other drugs that we can submit to the FDA..." We are on-track and moving forward towards the Milestones 4Q 2013.

Nanoviricides, Inc. will also have strong IP protection; well over 100 countries expected to approve patent applications by 4Q 2013; patents issued as "first in class" with no prior art.

Any idea if the next PR will be related to Nanoviricides/DengueCide application for Priority Review? Maybe next Friday or Monday? Confidence is high on NNVC!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News